definiens: shall mean ( i ) that certain Amended and Restated License Agreement, datedApril 30, 2007, by and between Tekmira Pharmaceuticals Corporation ( f / k / a Inex Pharmaceuticals Corporation ) andTalon Therapeutics, Inc. ( f / k / a Hana Biosciences, Inc. ), as amended on May 27, 2009 and September 20, 2010,(ii ) that certain Termination Agreement, dated May 6, 2002 by and between Tekmira Pharmaceuticals Corporation(f / k / a Inex Pharmaceuticals Corporation ) and British Columbia Cancer Agency, as amended by that certainAmendment to Termination Agreement, dated effective May 6, 2002, ( iii ) that certain Patent Technology LicenseAgreement, dated February 14, 2000 by and between The University of Texas M. D. Anderson Cancer Center andTekmira Pharmaceuticals Corporation ( f / k / a Inex Pharmaceuticals Corporation ) and assigned to Talon pursuant to thatcertain Assignment and Novation Agreement, dated April 30, 2007 and ( iv ) that certain Contingent Value RightsAgreement, dated as of January 16, 2012, by and between Talon Pharmaceuticals, Inc., Talon Therapeutics, Inc. andCorporate Stock Transfer, Inc. as Rights Agent ( ) ( which the Parties acknowledge is not a license butis included in this definition for administrative convenience ) . The Parties agree to amend this Section 1.77 to includesuch other agreement that Talon or its Affiliates have entered into as of the Effective Date that may affect Licensee’sexercise of the rights granted under this Agreement